Stockreport

Catalyst Pharmaceuticals Touts Firdapse Growth, Agamree Traction as Fycompa Faces Generics [Yahoo! Finance]

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com
PDF guiding 2026 revenue to $435M–$450M while noting low penetration (~30% idiopathic, Feb 2035) with one litigant (Hetero) still pending. Agamree has shown strong early c [Read more]